Methods in Cell Science

, Volume 21, Issue 1, pp 57–68 | Cite as

Rapid and efficient retrovirus-mediated gene transfer into B cell lines

  • Danielle L. Krebs
  • Yvonne Yang
  • May Dang
  • Jessica Haussmann
  • Michael R. Gold


Murine B cell lines such as WEHI-231, BAL17 and M12.4.1 are frequently used as model systems to study signal transduction, cell cycle regulation, and apoptosis. Dissection of these processes often involves expressing exogenous genes in these cells. Electroporation is an inefficient method to express genes in B cell lines and requires several weeks to isolate and analyze clones, followed by an additional one to two weeks to grow sufficient cells for biochemical experiments (e.g. immunoprecipitations). In this report, we describe an optimized procedure for retroviral-mediated gene transfer into murine B cell lines that allows one to obtain a pure population of cells expressing an exogenous gene within 4 days. Two days post-infection, between 10% (BAL17 and M12.4.1 cells) and 70% (WEHI-231 cells) of the cells express the exogenous gene. Culturing the cells for an additional 48 hours with puromycin kills all the non- infected cells and yields a pure population of cells that express the exogenous gene. Sufficient cells for biochemical experiments can be obtained by expanding the cell culture for an additional 5 to 7 days. This rapid and efficient retroviral-mediated gene transfer procedure can greatly expedite the study of signal transduction and other processes in B cells.

B cell line B lymphocyte Retroviral-mediate gene transfer Signal transduction 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gold MR, Matsuuchi L (1995). Signal transduction by the antigen receptors of B and T lymphocytes. Int Rev Cytol 157: 181–276.Google Scholar
  2. 2.
    Healy JI, Goodnow CC (1998). Positive versus negative signaling by lymphocyte antigen receptors. Ann Rev Immunol 16: 645–670.Google Scholar
  3. 3.
    Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S (1994). The CD40 antigen and its ligand. Ann Rev Immunol 12: 881–922.Google Scholar
  4. 4.
    O'Rourke L, Tooze R, Fearon DT (1997). Co-receptors of B lymphocytes. Curr Opin Immunol 9: 324–329.Google Scholar
  5. 5.
    Coogeshall KM (1998). Inhibitory signaling by B cell FcγRIIb. Curr Opin Immunol 10: 306–312.Google Scholar
  6. 6.
    DeFranco AL (1987). Molecular aspects of Blymphocyte activation. Ann Rev Cell Biol 3: 143–178.Google Scholar
  7. 7.
    Warner NL, Daley MJ, Richey J, Spellman C (1979). Flow cytometry analysis of murine B cell lymphoma differentiation. Immunol Rev 48: 197–243.Google Scholar
  8. 8.
    DeFranco AL, Davis MM, Paul WE (1982). WEHI-231 as a tumor model for tolerance induction in immature B lymphocytes. In: Vitetta E (ed), B and T cell tumors: biological and clinical aspects, pp 445–450. New York: Academic Press.Google Scholar
  9. 9.
    Boyd AW, Schrader JW (1981). The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI-231 by antiimmunoglobulin antibodies. J Immunol 126: 2466–2469.Google Scholar
  10. 10.
    Benhamou LE, Cazenave PA, Sarthou P (1990). Antiimmunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 20: 1405–1407.Google Scholar
  11. 11.
    Hasbold J, Klaus GGB (1990). Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol 20: 1685–1690.Google Scholar
  12. 12.
    Tsubata T, Wu J, Honjo T (1993). B-cell apoptosis induced by antigen receptor crosslinking is blocked by T-cell signal through CD40. Nature 364: 645–648.Google Scholar
  13. 13.
    Gold MR, Gajewski TF, DeFranco AL (1991). Regulation of anti-immunglobulin-induced B lymphoma growth arrest by transforming growth factor β1 and dexamethasone. Int Immunol 3: 1091–1098.Google Scholar
  14. 14.
    Arsura M, Wu M, Sonenshein GE (1996). TGFβ1 inhibits NF-кB/Rel activity inducing apoptosis of B cells: transcriptional activation of IкBα. Immunity 5: 31–40.Google Scholar
  15. 15.
    Gold MR, Aebersold R (1994). Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells. J Immunol 152: 42–50.Google Scholar
  16. 16.
    Goldstein MD, Watts TH (1996). Identification of distinct domains in CD40 involved in B7–1 induction or growth inhibition. J Immunol 157: 2837–2843.Google Scholar
  17. 17.
    Hsing Y, Hostager BS, Bishop GA (1997). Characterization of CD40 signaling determinants regulating nuclear factor-кB activation in B lymphocytes. J Immunol 159: 4898–4906.Google Scholar
  18. 18.
    Miller AD, Rosman GJ (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980–990.Google Scholar
  19. 19.
    Hock RA, Miller AD, Osborne WRA (1989). Expression of human adenosine deaminase from various strong promoters after gene transfer into human hematopoietic cell lines. Blood 74: 876–881.Google Scholar
  20. 20.
    Onishi M, Kinoshita S, Morikawa Y, Shibuya A, Phillips J, Lanier LL, Gorman DM, Nolan GP, Miyajima A, Kitamura T (1996). Applications of retrovirus-mediated expression cloning. Exp Hematol 24: 324–329.Google Scholar
  21. 21.
    Hawley RG, Lieu FHL, Fong AZC, Hawley TS (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Therapy 1: 136–138.Google Scholar
  22. 22.
    Kolanus W, Romeo C, Seed B (1993). T cell activation by clustered tyrosine kinases. Cell 74: 171–183.Google Scholar
  23. 23.
    Kim KJ, Kanellopoulos-Langevin C, Merwin RM, Sachs DH, Asofsky R (1979). Establishment and characterization of Balb/c lymphoma cell lines with B cell properties. J Immunol 122: 549–554.Google Scholar
  24. 24.
    Pear WS, Nolan GP, Scott ML, Baltimore D (1993). Production of high titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392–8396.Google Scholar
  25. 25.
    Fleit HB, Wright SD, Unkeless JC (1982). Human neutrophil Fc gamma receptor distribution and structure. Proc Natl Acad Sci USA 79: 3275–3279.Google Scholar
  26. 26.
    Bunnell BA, Mesler Muul L, Donahue RE, Blaese RM, Morgan RA (1995). High-efficiency retroviralmediated gene transfer into human and non-human primate peripheral blood lymphocyte. Proc Natl Acad Sci USA 92: 7739–7743.Google Scholar
  27. 27.
    Luciw PA, Oppermann H, Bishop JM, Varmus HE (1984). Integration and expression of several molecular forms of Rous sarcoma virus DNA used for transfection of mouse cells. Molec Cell Biol 4: 1260–1269.Google Scholar
  28. 28.
    Hwang LH, Gilboa E (1984). Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection. J Virol 50: 417–424.Google Scholar
  29. 29.
    Kim JW, Cross EI, Albritton L, Cunningham JM (1991). Transport of cationic amino acids by the mouse ecotroic retrovirus receptor. Nature 325: 725–738.Google Scholar
  30. 30.
    Wang H, Kavanaugh MP, North RA, Kabat D (1991). Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 325: 729–731.Google Scholar
  31. 31.
    Baker BW, Boettiger D, Spooncer E, Norton JD (1992). Efficient retroviral-mediated gene transfer into human B lymphoblastoid cells expressing mouse ecotropic viral receptor. Nucleic Acids Res 20: 5234.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Danielle L. Krebs
    • 1
  • Yvonne Yang
    • 1
  • May Dang
    • 1
  • Jessica Haussmann
    • 1
  • Michael R. Gold
    • 1
  1. 1.Department of Microbiology and ImmunologyThe University of British ColumbiaVancouverCanada

Personalised recommendations